Tele-epilepsy Market Size & Share, by Patient (Adult, Pediatric); Component; End use - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 6508
  • Published Date: Oct 03, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Tele-epilepsy Market size is estimated at USD 474.2 million in 2024 and is set to exceed USD 2.8 billion by the end of 2037, expanding at over 16.2% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of tele-epilepsy is assessed at USD 551.1 million.

The global tele-epilepsy market is expanding due to growing incidences of epilepsy and surging demand for remote management solutions. A 2024 report published by the World Health Organization (WHO) states that around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. Almost 80% of epileptics reside in low and middle-income nations.

Moreover, through the utilization of telemedicine technologies, patients have the opportunity to remotely consult with medical professionals such as neurologists and epileptologists, thereby eliminating the necessity for travel and transcending geographical barriers. Enhancing access to care has lead to improved patient outcomes and quality of life, stemming from early diagnosis, timely intervention, and enhanced epilepsy treatment.


Tele-epilepsy Market Overview
Get more information on this report: Request Free Sample PDF

Tele-epilepsy Sector: Growth Drivers and Challenges

Growth Drivers

  • Increased awareness of telehealth: Growing awareness and acceptance of telehealth, supportive government policies, and favorable reimbursement frameworks are expected to increase the adoption of tele-epilepsy services. For instance, in July 2024, a tool based on evidence was released by WHO Europe to assist nations in enhancing their telemedicine services. Support for telemedicine services at all levels, from local medical facilities to national health systems, is the goal of the Support tool to strengthen telemedicine.

    Moreover, telemedicine will continue to be essential in enhancing patients' access to care for those with epilepsy and other chronic disorders as it is more thoroughly incorporated into chronic care management.
  • Supportive government programs: The surge in support from the government and international organizations for epilepsy in developed countries is propelling the growth of the tele-epilepsy market. For instance, WHO released its Intersectoral Global Action Plan (IGAP) on epilepsy and other neurological disorders in July 2023. It was published in all six UN languages and lays out the steps that must be taken to improve access to care and treatment for those who suffer from neurological disorders using an all-encompassing, sector-wide coordinated response. Also, the Government of India has made a concerted effort to include neurological conditions such as epilepsy in its current healthcare initiatives. It has been successful for the National and District Mental Health Programs to give neurological conditions like dementia and epilepsy priority treatment.
  • Growing demand for remote monitoring and personalized care: With tele-epilepsy, patients' seizure activity, medication compliance, and other pertinent health indicators can be remotely monitored. Healthcare professionals can collect real-time data by integrating wearable technology, smart sensors, and mobile health apps. This enables more precise evaluation and individualized treatment of epilepsy. Moreover, this ongoing observation can help with medication regimen adjustment, early identification of changes in seizure patterns, and prompt emergency intervention. Tele-epilepsy platforms can also help with longitudinal data collecting, allowing medical professionals to monitor a patient's condition and personalize treatment plans according to their specific needs.

Challenges

  • Data security concerns: Sensitive health data is transmitted and stored through digital networks in cases of tele-epilepsy. Maintaining patient trust and adhering to healthcare laws such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States requires protecting the security and privacy of patient data. However, there are possible risks associated with data transmission over telecommunications networks, such as cyberattacks, unauthorized access, and data breaches which may pose security risks and hinder the growth of the market.
  • Digital divide and accessibility issues: Adoption of tele-epilepsy services is significantly limited by the digital divide, which is described as shifts in access to and usage of digital technologies based on socioeconomic status, geography, and other demographic characteristics. It may be difficult for those without access to dependable computers, smartphones, or internet connections to engage in teleconsultations, attend teletherapy sessions, or efficiently use remote monitoring equipment.

Tele-epilepsy Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

16.2%

Base Year Market Size (2024)

USD 474.2 million

Forecast Year Market Size (2037)

USD 2.8 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Tele-epilepsy Segmentation

Patient (Adult, Pediatric)

Adult segment is projected to account for more than 57.4% tele-epilepsy market share by the end of 2037. The segment growth can be attributed to the increasing adult population globally. The increasing likelihood of severe complications following a seizure in an adult with epilepsy underscores the importance of tele-epilepsy. Since epilepsy can be caused by strokes, brain tumors, or Alzheimer's disease, the number of new instances of epilepsy starts to rise around the age of 55.

Additionally, the pediatric segment is expected to hold a share of 43.0% during the forecast period. Since children have stronger immune levels and are less susceptible to other diseases, cases of epilepsy in children differ from those in adults in terms of seizure type and epilepsy syndrome. For instance, brain tumors, cysts, and degenerative disorders—conditions that grow and deteriorate over time and are frequently linked to the loss of brain cells—are less frequent causes of epilepsy in children.

Component (Software, Hardware, Service)

By the end of 2037, hardware segment is expected to capture around 42.7% tele-epilepsy market share. The segment growth can be attributed to the widespread use of audio equipment, microphones, videoconferencing technology, and other medical accessories to facilitate virtual visits. Moreover, companies are securing regulatory approvals for new epilepsy treatments, thus expanding the range of options available to patients, making telemedicine platforms more relevant as they integrate new therapies. For instance, leading medical technology company LivaNova PLC also known as LivaNova announced that its Vagus Nerve Stimulation Therapy (VNS Therapy) System, which consists of the SenTiva Generator and next-generation Programming System, has been granted the CE Mark for the treatment of patients with drug-resistant epilepsy (DRE).

End use (Hospital Providers, Payers, Healthcare Consumers)

In tele-epilepsy market, hospital providers segment is predicted to dominate over 37.8% revenue share by 2037. Hospitals are increasingly utilizing telemedicine to connect patients with neurologists and epileptologists, improving access to specialized care, especially in rural areas. Many hospitals are adopting integrated telehealth solutions that combine in-person and virtual care, enhancing patient management and follow-up. Moreover, hospitals are leveraging tele-epilepsy for remote patient monitoring in clinical trials, expanding research opportunities and improving treatment protocols.

Our in-depth analysis of the tele-epilepsy market includes the following segments:

Patient

  • Adult
  • Pediatric

Component

  • Software
  • Hardware
  • Service

End use

  • Hospital Providers
  • Payers
  • Healthcare Consumers

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Tele-epilepsy Industry - Regional Synopsis

North America Market Statistics

North America in tele-epilepsy market is projected to hold more than 38.3% revenue share by 2037. The market growth is expected on account of the rising infrastructure technology, the increase in epilepsy cases, and the growth in per capita income. Also, favorable government regulations and the presence of market players are propelling market growth in the region.

The increasing use of telemedicine services and products in the U.S., as well as advantageous government initiatives for epilepsy, are escalating the market growth in the country. According to the Centers for Disease Control and Prevention, in 2022, with age, the percentage of persons using telemedicine rose: among those aged 18 to 29, it was 29.4%; among those over 65, it was 43.3%.

In Canada, the surge in the adoption of smartphones and Internet services is driving the tele-epilepsy market. In 2020, the vast majority of individuals between the ages of 15 and 44 (96%) and 45 and 64 (87%), reported owning a smartphone. Use of wearable devices and mobile applications to track seizures and medication adherence, provide real-time data to healthcare providers.

APAC Market Analysis

Asia Pacific will encounter huge growth for the tele-epilepsy market during the forecast period. The market is expanding due to the widespread use of cutting-edge technology and improved network access. The COVID-19 pandemic accelerated the adoption of telehealth services, with many healthcare providers offering virtual consultations and remote monitoring options.

In China, the increasing prevalence of epilepsy and growing government program offerings are major factors accelerating the market growth. Based on epidemiological surveys, approximately 10 million people in China suffer from epilepsy, with 400,000 to 600,000 new cases being reported each year. In China, epilepsy is still a major health concern, especially in the western provinces.

In India, increased awareness of epilepsy and available treatments among the general public and medical professionals are fueling tele-epilepsy market growth. For instance, every year on November 17, India observes National Epilepsy Day to increase public awareness of the disease and its effects on the individuals, families, and communities it affects.

The burden of lifelong epilepsy in South Korea is expected to rise significantly, in line with global trends, due to the country's aging population. Also, growing adoption of artificial intelligence for EEG analysis, wearable seizure detection devices, and non-invasive brain stimulation methods is boosting the tele-epilepsy market expansion.

Research Nester
Tele-epilepsy Market Share
Get more information on this report: Request Free Sample PDF

Companies Dominating the Tele-epilepsy Landscape

    Major players in the tele-epilepsy market are increasingly focused on strategic partnerships with technology providers and product development. In addition, they are implementing strategies such as mergers and acquisitions, product and service launches, partnerships, joint ventures, collaborations, and expansions to improve their position in the tele-epilepsy market.

    • Invitae Corp.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • NeuroPace Inc.
    • Empatica Inc.
    • Eagle Telemedicine
    • Sevaro
    • TeleSpecialists, LLC
    • Chiron Health
    • Natus Medical, Inc.
    • Compumedics Limited
    • Medtronic Plc

In the News

  • In July 2024, Invitae, a leading medical genetics company, announced the launch of its Unlock Behind the Seizure program, which provides accessible and affordable genetic testing for pediatric epilepsy patients. The program aims to shorten the diagnostic odyssey and enable a path toward effective, personalized care and precision therapy.
  • In August 2021, NeuroPace, Inc., a medical technology company dedicated to improving the lives of people with epilepsy, announced the general availability of its nSight Platform, an online portal that enables physicians to provide more personalized, data-driven epilepsy care by allowing them to remotely review patient progress, discover actionable insights, and track their clinic's overall patient outcomes.

Author Credits:  Radhika Pawar


  • Report ID: 6508
  • Published Date: Oct 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of tele-epilepsy is over USD 474.2 million.

The market size for tele-epilepsy is projected to cross USD 2.8 billion by the end of 2037 expanding at a CAGR of 16.2% during the forecast period i.e., between 2025-2037.

The major players in the market are Invitae Corp., NeuroPace Inc., Empatica Inc., Eagle Telemedicine, Sevaro, TeleSpecialists, LLC, Chiron Health, Natus Medical, Inc., Compumedics Limited, Medtronic Plc, and others.

The adult segment is anticipated to garner a share/size of 57.4% during 2025-2037.

The North America tele-epilepsy sector is poised to hold 38.3% share by the end of 2037.
Tele-epilepsy Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample